Source: Virtual Congress 2021 – Pulmonary hypertension in the COVID-19 pandemic and beyond



Rating:

Share or cite this content

Citations should be made in the following way:
A. Volkov (MOSCOW, Russian Federation), O. Alexeeva (MOSCOW, Russian Federation), E. Nikolaeva (MOSCOW, Russian Federation). Distance assessment of the risk of pulmonary hypertension associated with connective tissue diseases: do biomarkers help?. 3601

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for pulmonary hypertension and associations with lung function in connective tissue diseases Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment Source: ERJ Open Res, 7 (3) 00854-2020; 10.1183/23120541.00854-2020 Year: 2021 Pulmonary arterial hypertension associated with connective tissue disease: an integrated approach Source: Annual Congress 2008 - Mastering pulmonary arterial hypertension: defined by evidence - enhanced by experience Year: 2008 Oxygen pulse slope analysis during exercise testing identifies patients with systemic sclerosis at a possible risk for developing pulmonary vasculopathy Source: Annual Congress 2013 –Clinical exercise physiology Year: 2013 Refining definitions of time to clinical worsening in connective tissue disease-associated pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Undifferentiated connective tissue disease at risk for systemic sclerosis: is heart function already impaired? Source: International Congress 2017 – PAH and CTEPH Year: 2017 Connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment Source: Eur Respir Rev 2014; 23: 505-509 Year: 2014 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 ¿Idiopathic pulmonary fibrosis or interstitial lung disease associated to connective tissue diseases? Endothelial progenitor cells as a potential tool for the differential diagnosis Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 Exercise training in pulmonary arterial hypertension associated with connective tissue diseases Source: Annual Congress 2012 - Limiting factors in exercise Year: 2012 Acute effects of oxygen on pulmonary hemodynamic can help in differentiation of pulmonary hypertension at patients with connective tissue diseases Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Does lung function predict response to therapy in PAH associated with connective tissue disease? Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Veno-occlussive lesions and inflammation in pulmonary arterial hypertension associated with connective tissue diseases Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007 Optimising pharmacotherapy in patients with pulmonary arterial hypertension and comorbidities, including lung diseases and heart failure: benefits without harm? Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure Year: 2018 Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Double combination therapy in patients with pulmonary arterial hypertension associated with connective tissue disease Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Pulmonary hypertension in patients with lupus: Prevalence, etiology and risk factors Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries Year: 2012 Are risk predicting models useful for estimating survival in rheumatoid arthritis-associated interstitial lung disease? Source: International Congress 2016 – Connective tissue disorders Year: 2016 Risk assessment in severe pulmonary hypertension due to interstitial lung disease Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Biomarkers in pulmonary hypertension associated to interstitial lung disease Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010